Dr. Bernhard Ehmer

Dr. Bernhard Ehmer

Chairman of the Supervisory Board
Heidelberg, Germany
Shareholder representative
Member since: May 2022

 

Personal Information

Date of Birth: 03 February 1955  
Place of Birth: Kandel, Germany
Nationality: German

Education

Faculty of Medicine, Ruprecht-Karls-University of Heidelberg, 1976 - 1982

Career

2014 – 2019 Biotest AG, CEO
2008 - 2012 Imclone Group
  • Imclone Systems Corporation, President
  • Imclone Systems International GmbH, Managing Director
    and Senior VP
2007 - 2008 Fresenius Biotech, CEO
2006 - 2007 Biopheresis GmbH & Inc., CEO & Managing Director
1998 - 2006

Merck Group

  • Merck KGaA, Head Corporate Strategic Planning &
    Alliance Management, Vice President
  • Merck KGaA/EMD Pharmaceuticals Head Business Area Oncology,
    Vice President
  • Merck KGaA Darmstadt, Head of Clinical R&D Operations
1986 - 1998

Boehringer Mannheim

  • Boehringer Mannheim GmbH, Head Therapeutics
    (Regional Office Singapure), Head of Medical Operations
  • Boehringer Mannheim Monza (Italy), Medical Project Leader
  • Boehringer Mannheim GmbH, Medical Advisor &
    Medical Project Leader
1983 - 1986 Academic Teaching Hospital University of Heidelberg,
Resident Internal Medicine

Membership in Supervisory Boards and Comparable Controlling Bodies

Affimed N.V. – Member of the Board